Amphastar Pharmaceuticals, Inc. AMPH

26.13 (0.14) (0.53%) as of 25 Sep
Market cap
$1.1B
P/E
15.0×

An Income Statement, also known as a Profit and Loss Statement, summarizes a company's revenues, expenses, and profits over a specific period. It highlights how revenue is transformed into net income, showcasing operational efficiency. Key components include total revenue, cost of goods sold (COGS), gross profit, operating expenses, and net profit. Businesses use the Income Statement to assess financial performance, make strategic decisions, and ensure profitability. Investors and stakeholders analyze it to gauge the company’s financial health and future growth potential.

Jun '26 Mar '26 Dec '25 Sep '25 Older periods
Revenue
730.02 720.53 719.89 723.31

+8 more TTM periods

Gross Profit
348.11 341.13 356.06 357.04
Operating Income
114.29 116.74 140.40 149.94
EBT
102.02 102.81 123.62 135.67
Income after Tax
78.55 79.23 98.09 111.63
Net Income Common
78.55 79.23 98.09 111.63
Gross Margin
47.68% 47.34% 49.46% 49.36%
EBIT Margin
15.66% 16.20% 19.50% 20.73%
Net Profit Margin
10.76% 11.00% 13.63% 15.43%
Free Cash Flow Margin
20.94% 18.76% 16.51% 15.33%
EBITDA
174.80 177.53 200.45 208.94
EBIT
114.29 116.74 140.40 149.94

Show all line items

In millions of $ except per-share values · columns are period end dates